HIV-infection

Viral Hepatitis E in Patients with Secondary Immunodeficiency

Клиническая Микробиология и Антимикробная Химиотерапия. 2014; 16(3):195-201

This paper presents a comparative analysis of distribution of hepatitis A, B, C and E as well as opportunistic infections among immunosuppressed patients and healthy people. Results of this epidemiological study suggest hepatitis E as an …

Identification of a Novel MRSA ST239 Strain Producing Toxic Shock Syndrome Toxin (TSST-1) in a HIV-infected Patient with Pneumonia

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):346-353

Methicillin-resistant Staphylococcus aureus (MRSA) ST239 is one of the most common nosocomial genotypes worldwide. Typical MRSA ST239 strains do not produce toxic shock syndrome toxin-1 (TSST-1), which is encoded by tst gene at staphylococcal …

Health Economic Issues of the Treatment of HIV-infection and AIDS

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):67-76

Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) are one of the most important problems in modern medicine. Authors performed a review of international health economic studies of the HIV/AIDS treatment. …

Antiretroviral drugs

Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):360-379

Antiretroviral drugs today are the basis of HIV therapy. The severe and progressive nature of the disease and the need for lifelong therapy make the correct choice of drugs for HIV therapy of particular importance. Alarge number of antiretroviral …